Net profit of Natco Pharma rose 327.20% to Rs 320.40 crore in the quarter ended June 2022 as against Rs 75.00 crore during the previous quarter ended June 2021. Sales rose 115.60% to Rs 884.60 crore in the quarter ended June 2022 as against Rs 410.30 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 884.60 | 410.30 | 116 |
| OPM % | 44.69 | 26.76 | – |
| PBDT | 425.40 | 124.80 | 241 |
| PBT | 385.80 | 91.00 | 324 |
| NP | 320.40 | 75.00 | 327 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
